# Enemeez, LLC dba Summit Pharmaceuticals – FDA Inspection, Jul 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/7e7bbba6-611e-4478-a3de-f582c1b59bd4
Source feed: FDA_Inspections

> FDA inspection 1147428 of Enemeez, LLC dba Summit Pharmaceuticals, July 29, 2021. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1147428
- Company Name: Enemeez, LLC dba Summit Pharmaceuticals
- Inspection Date: 2021-07-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1302518 - 2026-02-12](https://www.keypedia.com/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/12a25bf5-77ce-4384-a93c-ff5f6e98e524)
- [FDA Inspection 987440 - 2016-08-10](https://www.keypedia.com/records/fda_inspections/enemeez-llc-dba-summit-pharmaceuticals/dc80d110-051f-497b-9582-53e15040cdf4)
- FDA Inspection 728243 - 2011-06-06
- FDA Inspection 656042 - 2010-03-12

Company: https://www.keypedia.com/companies/enemeez-llc-dba-summit-pharmaceuticals/dd1473a2-9b40-4ff6-a713-f83d1ba98c4f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
